2019/07/04 Journal Club
The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity (PubMed Link)
2019/07/04 Journal Club Read More »
The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity (PubMed Link)
2019/07/04 Journal Club Read More »
CancerLinQ: CancerLinQ LLC is a not-for-profit subsidiary of the American Society of Clinical Oncology (ASCO) established for the development and operation of the CancerLinQ initiative.[1]. CancerLinQ is a health information technology platform aimed at enhancing and improving the understanding and treatment of cancer. This program was created to give oncologists a robust quality monitoring system
2019 ASCO Meeting-Caring for Every Patient, Learning From Every Patient Read More »
Patient-Derived Xenografts for Prognostication and Personalized Treatment for Headand Neck Squamous Cell Carcinoma. (PubMed Link)
2019/06/20 Journal Club Read More »